drugset / Trial / NCT01504282
Mitomycin-c Application for PRK
RandomizedParallel-groupQuadruple-blindPrevention
Summary
To evaluate the safety and efficacy of 5 seconds mitomycin-C (MMC) application during photorefractive keratectomy (PRK) for patients with low myopia.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Mitomycin C | Other / unclassified | 0.02 % | Topical |